首页 > 最新文献

Pharmatherapeutica最新文献

英文 中文
Controlled study of the effects of tiropramide on biliary dyskinesia. 替洛普胺治疗胆道运动障碍的对照研究。
Pub Date : 1986-01-01
E Trabucchi, C Baratti, A Centemero, M Zuin, E Rizzitelli, R Colombo

A controlled trial was carried out in patients with biliary dyskinesia to compare the effects of the new calmodulin-independent and antispastic drug tiropramide with those of imecromone. Forty patients were randomly divided into two groups, one treated with 300 mg tiropramide per day and the other with 1200 mg imecromone per day, both treatments lasting for 3 months. The results showed that tiropramide was significantly more effective in decreasing the number of attacks of pain and in improving pain and dyspepsia symptoms than imecromone. In subjects with delayed filling of the gall bladder during cholecystography, tiropramide but not imecromone was able to normalize the condition. These results confirm the antispastic synchronizing effect of tiropramide on the motor activity of the gall bladder and the sphincter of Oddi and indicate that it should be the drug of choice for treatment of motor disorders of the biliary tract.

在胆道运动障碍患者中进行了一项对照试验,以比较新的不依赖钙调素的抗痉挛药物替罗普胺与亚胺酮的效果。40例患者随机分为两组,一组每日给予替罗普胺300 mg,另一组每日给予亚胺酮1200 mg,疗程均为3个月。结果表明,替罗普胺在减少疼痛发作次数、改善疼痛和消化不良症状方面明显优于亚胺酮。在胆囊造影时胆囊充盈延迟的受试者中,替罗普胺而非亚胺酮能够使病情正常化。这些结果证实了替罗普胺对胆囊和Oddi括约肌运动活动的抗痉挛同步作用,表明它应该是治疗胆道运动障碍的首选药物。
{"title":"Controlled study of the effects of tiropramide on biliary dyskinesia.","authors":"E Trabucchi,&nbsp;C Baratti,&nbsp;A Centemero,&nbsp;M Zuin,&nbsp;E Rizzitelli,&nbsp;R Colombo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A controlled trial was carried out in patients with biliary dyskinesia to compare the effects of the new calmodulin-independent and antispastic drug tiropramide with those of imecromone. Forty patients were randomly divided into two groups, one treated with 300 mg tiropramide per day and the other with 1200 mg imecromone per day, both treatments lasting for 3 months. The results showed that tiropramide was significantly more effective in decreasing the number of attacks of pain and in improving pain and dyspepsia symptoms than imecromone. In subjects with delayed filling of the gall bladder during cholecystography, tiropramide but not imecromone was able to normalize the condition. These results confirm the antispastic synchronizing effect of tiropramide on the motor activity of the gall bladder and the sphincter of Oddi and indicate that it should be the drug of choice for treatment of motor disorders of the biliary tract.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 9","pages":"541-50"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13576848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of theophylline in a slow-release 'sprinkle' format with a standard syrup preparation in young children with asthma. 茶碱缓释“洒”形式与标准糖浆制剂在幼儿哮喘中的比较研究。
Pub Date : 1986-01-01
K P Dawson

Sixty-one chronic asthmatic children received either a new slow-release sprinkle format of theophylline, twice daily, or theophylline liquid, 4-times per day. Over a study period of three months, there was no measurable difference in compliance or symptom control between the two groups. The sprinkle-treated patients, however, had a greater incidence of side-effects and had higher rates of nebulization with beta-agonists. Possible explanations are discussed.

61名慢性哮喘患儿接受新的缓释茶碱滴注治疗,每日2次,或茶碱液体治疗,每日4次。在三个月的研究期间,两组在依从性或症状控制方面没有可测量的差异。然而,使用喷雾剂治疗的患者副作用发生率更高,使用β激动剂雾化的比例也更高。讨论了可能的解释。
{"title":"A comparative study of theophylline in a slow-release 'sprinkle' format with a standard syrup preparation in young children with asthma.","authors":"K P Dawson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Sixty-one chronic asthmatic children received either a new slow-release sprinkle format of theophylline, twice daily, or theophylline liquid, 4-times per day. Over a study period of three months, there was no measurable difference in compliance or symptom control between the two groups. The sprinkle-treated patients, however, had a greater incidence of side-effects and had higher rates of nebulization with beta-agonists. Possible explanations are discussed.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 7","pages":"442-4"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15076275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferritin versus ferrous sulphate preparations: a controlled study in sideropaenic patients. 铁蛋白与硫酸亚铁制剂:铁缺乏患者的对照研究。
Pub Date : 1986-01-01
G Sás, K Scheffer, G Schreiber, H Bräuer, G Ceccarelli

A double-blind study was carried out in 54 patients requiring iron therapy to compare the effects of orally administered bivalent and trivalent iron over a period of 12 weeks. Patients were allocated at random to receive ferrous sulphate (100 mg/day), ferritin (80 mg/day as Fe3+) or a combination of ferritin (80 mg Fe3+/day), folinic acid and vitamin B12 coenzyme. Haematological measurements made before and during treatment showed that, whilst there were significant improvements in all of the parameters studied with both the bivalent and trivalent forms of iron, the results were more progressive and consistent with the two ferritin preparations, indicating that ferritin is clinically effective as a physiological iron donor in sideropaenic conditions.

一项双盲研究对54名需要铁治疗的患者进行了为期12周的比较口服二价铁和三价铁的效果。患者随机分配接受硫酸亚铁(100 mg/天)、铁蛋白(80 mg/天作为Fe3+)或铁蛋白(80 mg Fe3+/天)、叶酸和维生素B12辅酶的组合治疗。治疗前和治疗期间的血液学测量显示,虽然二价和三价形式的铁在所有研究参数上都有显著改善,但结果更进步,与两种铁蛋白制剂一致,表明铁蛋白作为铁缺乏症的生理铁供体在临床上是有效的。
{"title":"Ferritin versus ferrous sulphate preparations: a controlled study in sideropaenic patients.","authors":"G Sás,&nbsp;K Scheffer,&nbsp;G Schreiber,&nbsp;H Bräuer,&nbsp;G Ceccarelli","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A double-blind study was carried out in 54 patients requiring iron therapy to compare the effects of orally administered bivalent and trivalent iron over a period of 12 weeks. Patients were allocated at random to receive ferrous sulphate (100 mg/day), ferritin (80 mg/day as Fe3+) or a combination of ferritin (80 mg Fe3+/day), folinic acid and vitamin B12 coenzyme. Haematological measurements made before and during treatment showed that, whilst there were significant improvements in all of the parameters studied with both the bivalent and trivalent forms of iron, the results were more progressive and consistent with the two ferritin preparations, indicating that ferritin is clinically effective as a physiological iron donor in sideropaenic conditions.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 10","pages":"673-8"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14427953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effectiveness of oral midazolam as a hypnotic compared with lorazepam. 口服咪达唑仑与劳拉西泮的催眠效果比较。
Pub Date : 1986-01-01
A Lorizio, F Salsa

A double-blind closed sequential scheme study was carried out in 82 patients with insomnia to compare the hypnotic effectiveness of 15 mg midazolam and 1 mg lorazepam. Pairs of randomized patients were treated on one and the same night with midazolam or lorazepam, respectively. Eight parameters were recorded for each member of the pair. The time taken to fall asleep, the duration of sleep and the overall assessment of response showed that midazolam was significantly superior to lorazepam: the number of awakenings and evaluation by the patient verged on statistical significance. Both drugs were equal for the quality of sleep, dreams and the patient's condition on awakening. No side-effects were observed in any of the patients.

对82例失眠症患者进行双盲封闭序贯方案研究,比较15 mg咪达唑仑与1 mg劳拉西泮的催眠效果。对随机患者分别在一个晚上和同一个晚上接受咪达唑仑或劳拉西泮治疗。记录了这对中的每个成员的8个参数。入睡时间、睡眠持续时间和总体反应评价显示咪达唑仑明显优于劳拉西泮:苏醒次数和患者评价接近统计学意义。两种药物对睡眠质量、梦境和患者醒来时的状况都是相同的。没有观察到任何患者的副作用。
{"title":"The effectiveness of oral midazolam as a hypnotic compared with lorazepam.","authors":"A Lorizio,&nbsp;F Salsa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A double-blind closed sequential scheme study was carried out in 82 patients with insomnia to compare the hypnotic effectiveness of 15 mg midazolam and 1 mg lorazepam. Pairs of randomized patients were treated on one and the same night with midazolam or lorazepam, respectively. Eight parameters were recorded for each member of the pair. The time taken to fall asleep, the duration of sleep and the overall assessment of response showed that midazolam was significantly superior to lorazepam: the number of awakenings and evaluation by the patient verged on statistical significance. Both drugs were equal for the quality of sleep, dreams and the patient's condition on awakening. No side-effects were observed in any of the patients.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 7","pages":"463-71"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14074660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fusidic acid-betamethasone combination in infected eczema: an open, randomized comparison with gentamicin-betamethasone combination. 氟西地酸-倍他米松联合治疗感染性湿疹:与庆大霉素-倍他米松联合的开放、随机比较
Pub Date : 1986-01-01
J Strategos

Ninety-nine patients with secondarily infected eczema were allocated at random to receive 10-days' treatment with either 2% fusidic acid plus 0.1% betamethasone cream or 0.1% gentamicin plus 0.1% betamethasone cream. Both preparations were applied to the lesions twice daily and assessment of the signs and symptoms was carried out before, after 2 to 4 days, and after 7 to 12 days of treatment, severity being rated on a 4-point scale. Bacteriological tests were carried out before and after treatment. The results showed that the combination with fusidic acid was marginally superior in clinical effect. Staphylococcus aureus was the most commonly isolated pathogen from eczematous lesions (86%) and fusidic acid showed the lowest resistance rate (9%), followed by gentamicin (21%). Chloramphenicol, neomycin and tetracycline showed resistance rates from 48% to 59%.

99例继发性感染湿疹患者随机分配,接受2%夫西地酸加0.1%倍他米松乳膏或0.1%庆大霉素加0.1%倍他米松乳膏的10天治疗。这两种制剂每天两次应用于病变,并在治疗前、治疗后2至4天和治疗后7至12天对症状和体征进行评估,严重程度按4分制评定。治疗前后分别进行细菌学检查。结果表明,与夫西地酸联用在临床疗效上略胜一筹。金黄色葡萄球菌是最常见的湿疹病原菌(86%),夫西地酸耐药率最低(9%),庆大霉素次之(21%)。氯霉素、新霉素和四环素的耐药率为48% ~ 59%。
{"title":"Fusidic acid-betamethasone combination in infected eczema: an open, randomized comparison with gentamicin-betamethasone combination.","authors":"J Strategos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ninety-nine patients with secondarily infected eczema were allocated at random to receive 10-days' treatment with either 2% fusidic acid plus 0.1% betamethasone cream or 0.1% gentamicin plus 0.1% betamethasone cream. Both preparations were applied to the lesions twice daily and assessment of the signs and symptoms was carried out before, after 2 to 4 days, and after 7 to 12 days of treatment, severity being rated on a 4-point scale. Bacteriological tests were carried out before and after treatment. The results showed that the combination with fusidic acid was marginally superior in clinical effect. Staphylococcus aureus was the most commonly isolated pathogen from eczematous lesions (86%) and fusidic acid showed the lowest resistance rate (9%), followed by gentamicin (21%). Chloramphenicol, neomycin and tetracycline showed resistance rates from 48% to 59%.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 9","pages":"601-6"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14882806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-prostatectomy auto-irrigation with furosemide in the tropics. 热带地区前列腺切除术后用速尿自动冲洗。
Pub Date : 1986-01-01
A H Fahal, A Ibrahim

A progressive study was carried out in 49 patients who underwent prostatectomy (10 transurethrally and 39 transvesically) to assess the effects of furosemide given intravenously for post-operative bladder irrigation. All 10 transurethral patients and 17 of the transvesical patients received furosemide, the remaining 22 patients receiving formal external bladder irrigation with saline. The results showed that post-operative infection was lowest and bed stay shortest in the patients with furosemide auto-irrigation. There was also less need for blood transfusion. No significant changes in haemoglobin and packed cell volume were observed in the transurethral patients; however, both decreased significantly in all 39 patients with transvesical prostatectomy, whether or not furosemide was used. Auto-irrigation with furosemide was found to be associated with a significant post-operative decrease in serum potassium but not in serum sodium levels. When external irrigation with saline was used, there was a significant increase in serum sodium.

对49例前列腺切除术患者(10例经尿道,39例经膀胱)进行了一项渐进式研究,以评估静脉滴注速尿用于术后膀胱冲洗的效果。10例经尿道患者和17例经膀胱患者均使用速尿,其余22例接受盐水膀胱外冲洗。结果表明,速尿自动冲洗组术后感染最低,住院时间最短。输血的需求也减少了。经尿道患者血红蛋白和堆积细胞体积未见明显变化;然而,在所有39例经膀胱前列腺切除术患者中,无论是否使用速尿,两者均显著下降。发现用速尿自动冲洗与术后血清钾显著下降有关,但与血清钠水平无关。经生理盐水外灌后,血清钠明显升高。
{"title":"Post-prostatectomy auto-irrigation with furosemide in the tropics.","authors":"A H Fahal,&nbsp;A Ibrahim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A progressive study was carried out in 49 patients who underwent prostatectomy (10 transurethrally and 39 transvesically) to assess the effects of furosemide given intravenously for post-operative bladder irrigation. All 10 transurethral patients and 17 of the transvesical patients received furosemide, the remaining 22 patients receiving formal external bladder irrigation with saline. The results showed that post-operative infection was lowest and bed stay shortest in the patients with furosemide auto-irrigation. There was also less need for blood transfusion. No significant changes in haemoglobin and packed cell volume were observed in the transurethral patients; however, both decreased significantly in all 39 patients with transvesical prostatectomy, whether or not furosemide was used. Auto-irrigation with furosemide was found to be associated with a significant post-operative decrease in serum potassium but not in serum sodium levels. When external irrigation with saline was used, there was a significant increase in serum sodium.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 9","pages":"590-4"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14226075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. 阿司咪唑与特非那定治疗慢性荨麻疹的双盲比较。
Pub Date : 1986-01-01
T Cainelli, S Seidenari, R Valsecchi, M Mosca

Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria. The trial lasted 4 weeks. Patients were evaluated at 2 and 4 weeks and kept a daily diary of their symptoms. There was a statistically significant decrease in pruritus, erythema and urticaria papules in both groups throughout the study. Changes in papule size, number and frequency were greater in the astemizole group though not significantly different to the terfenadine group. The effect of astemizole increased with time whereas that of terfenadine decreased after about 3 weeks of treatment. Astemizole was globally considered to be the most effective drug by both investigator and patients, with excellent/good results in 77% of the patients compared with 55% to 60% in the terfenadine group. Both drugs were reported to be more effective and faster acting than other antihistamines taken previously. Side-effects were infrequent and minor in both groups.

在一项对42例慢性荨麻疹成年患者的双盲随机研究中,比较了两种新的非镇静抗组胺药阿司咪唑(每天10毫克)和特非那定(每天120毫克)。试验期4周。在第2周和第4周对患者进行评估,并记录每日症状日记。在整个研究过程中,两组患者的瘙痒、红斑和荨麻疹丘疹的发生率均有统计学上的显著下降。阿司咪唑组的丘疹大小、数量和频率变化较大,但与特非那定组无显著差异。阿司咪唑的作用随时间增加而增加,而特非那定的作用在治疗约3周后下降。阿司咪唑在全球范围内被研究者和患者认为是最有效的药物,77%的患者获得优异/良好的结果,而特非那定组为55%至60%。据报道,这两种药物比以前服用的其他抗组胺药更有效,作用更快。两组的副作用都很少,而且都很轻微。
{"title":"Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.","authors":"T Cainelli,&nbsp;S Seidenari,&nbsp;R Valsecchi,&nbsp;M Mosca","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Two new non-sedating antihistamines, astemizole (10 mg per day) and terfenadine (120 mg per day), were compared in a double-blind randomized study in 42 adult patients suffering from chronic urticaria. The trial lasted 4 weeks. Patients were evaluated at 2 and 4 weeks and kept a daily diary of their symptoms. There was a statistically significant decrease in pruritus, erythema and urticaria papules in both groups throughout the study. Changes in papule size, number and frequency were greater in the astemizole group though not significantly different to the terfenadine group. The effect of astemizole increased with time whereas that of terfenadine decreased after about 3 weeks of treatment. Astemizole was globally considered to be the most effective drug by both investigator and patients, with excellent/good results in 77% of the patients compared with 55% to 60% in the terfenadine group. Both drugs were reported to be more effective and faster acting than other antihistamines taken previously. Side-effects were infrequent and minor in both groups.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 10","pages":"679-86"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14022995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune therapy of osteoarthritis: an open assessment of clinical results with heterologous antibodies to articular tissue ('Serocytol'). 骨关节炎的免疫治疗:对关节组织异源抗体(Serocytol)临床结果的公开评估。
Pub Date : 1986-01-01
F Piccione, G Grecomoro, B Pinto, A Sanfilippo

Forty-three out-patients received treatment (6 months in 13 cases of spondylarthrosis, 12 months in 30 cases of gonarthrosis) with heterologous antibodies to articular tissue, given as 1 rectal suppository once every other day for periods of 4 weeks out of every 5. The treatment produced complete freedom from symptoms and signs of the illness in 5 (12%) patients and overall positive therapeutic results in 36 (84%), equally distributed in the disorders of the vertebral column and of the knee. This was accompanied by a significant improvement, both in terms of percentage improvement and the percentage of patients improved, of all monitored symptoms. The percentage improvement was similar for all components of the illness: pain, mobility and inflammatory-reactive component. No local or systemic side-reactions were recorded throughout the observation period, and there were no adverse effects on haematology, haematochemistry or renal function. A high percentage of patients reported a remarkable improvement in their quality of life, an overall measure of the therapeutic benefit-risk ratio as experienced by the individual patient.

43例门诊患者接受关节组织异源抗体治疗(脊柱性关节病13例6个月,膝关节病30例12个月),每隔一天给予1个直肠栓剂,每5周给予4周。治疗使5例(12%)患者的症状和体征完全消失,36例(84%)患者的治疗结果总体呈阳性,平均分布在脊柱和膝关节疾病中。在所有监测症状的改善百分比和患者改善百分比方面,这都伴随着显著的改善。该疾病的所有组成部分的改善百分比相似:疼痛、活动能力和炎症反应成分。在整个观察期间,没有记录到局部或全身的副作用,对血液学、血液化学或肾功能没有不良影响。很高比例的患者报告他们的生活质量有了显著的改善,这是个体患者所经历的治疗收益-风险比的总体衡量标准。
{"title":"Immune therapy of osteoarthritis: an open assessment of clinical results with heterologous antibodies to articular tissue ('Serocytol').","authors":"F Piccione,&nbsp;G Grecomoro,&nbsp;B Pinto,&nbsp;A Sanfilippo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Forty-three out-patients received treatment (6 months in 13 cases of spondylarthrosis, 12 months in 30 cases of gonarthrosis) with heterologous antibodies to articular tissue, given as 1 rectal suppository once every other day for periods of 4 weeks out of every 5. The treatment produced complete freedom from symptoms and signs of the illness in 5 (12%) patients and overall positive therapeutic results in 36 (84%), equally distributed in the disorders of the vertebral column and of the knee. This was accompanied by a significant improvement, both in terms of percentage improvement and the percentage of patients improved, of all monitored symptoms. The percentage improvement was similar for all components of the illness: pain, mobility and inflammatory-reactive component. No local or systemic side-reactions were recorded throughout the observation period, and there were no adverse effects on haematology, haematochemistry or renal function. A high percentage of patients reported a remarkable improvement in their quality of life, an overall measure of the therapeutic benefit-risk ratio as experienced by the individual patient.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 9","pages":"577-84"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14882804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The management of genital candidosis with an oral antimycotic agent, ketoconazole. 口服抗真菌药酮康唑治疗生殖器念珠菌病。
Pub Date : 1986-01-01
A Silva-Cruz, V Duarte

Fifty-three women with clinical evidence of vaginal candidosis confirmed by culture were entered into an open study. Patients received 400 mg ketoconazole once daily for 5 days. At 2 weeks post-treatment, 49 (92.5%) showed clinical and microbiological remission. The remaining 4 patients received 400 mg ketoconazole once daily for a further 21 days, along with a 400 mg 5-day course for their sexual partners. On completion of this second course of treatment, 3 of these patients were cured. Apart from some mild nausea, no side-effects were reported or observed.

53名经培养证实有阴道念珠菌病临床证据的妇女进入了一项开放研究。患者接受酮康唑400 mg,每日1次,连用5天。治疗2周后,49例(92.5%)临床和微生物缓解。其余4名患者接受400毫克酮康唑治疗,每天一次,持续21天,同时其性伴侣接受400毫克5天疗程。在完成第二期治疗后,其中3名患者治愈。除了一些轻微的恶心,没有报告或观察到副作用。
{"title":"The management of genital candidosis with an oral antimycotic agent, ketoconazole.","authors":"A Silva-Cruz,&nbsp;V Duarte","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Fifty-three women with clinical evidence of vaginal candidosis confirmed by culture were entered into an open study. Patients received 400 mg ketoconazole once daily for 5 days. At 2 weeks post-treatment, 49 (92.5%) showed clinical and microbiological remission. The remaining 4 patients received 400 mg ketoconazole once daily for a further 21 days, along with a 400 mg 5-day course for their sexual partners. On completion of this second course of treatment, 3 of these patients were cured. Apart from some mild nausea, no side-effects were reported or observed.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 7","pages":"411-5"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15076274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measurement of reaction times in tasks of varying complexity: an indication of the degree and evolution of mental deterioration in the elderly. 测量不同复杂任务的反应时间:老年人智力退化程度和进化的指示。
Pub Date : 1986-01-01
T Waegemans

In a group of 40 elderly patients with intellectual deterioration, slowing of behaviour was measured with an original reaction time apparatus. Three types of measurements in ascending degree of complexity were evaluated against each other. Intercorrelations, made with indicators of physical, mental and behavioural functioning, demonstrated that ascending complexity in reaction time measurements can be used as an evaluation of the degree of mental deterioration. An example of the use of the apparatus in the evaluation of the improvement after treatment with suloctidil is given.

在一组40名智力退化的老年患者中,用一种原始的反应时间仪器测量了他们的行为减慢。根据复杂度升序对三种测量方法进行了评价。与身体、心理和行为功能指标的相互关系表明,反应时间测量的复杂性上升可以用来评估精神退化的程度。给出了用该仪器评价舒洛地尔治疗后的改善情况的一个实例。
{"title":"Measurement of reaction times in tasks of varying complexity: an indication of the degree and evolution of mental deterioration in the elderly.","authors":"T Waegemans","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a group of 40 elderly patients with intellectual deterioration, slowing of behaviour was measured with an original reaction time apparatus. Three types of measurements in ascending degree of complexity were evaluated against each other. Intercorrelations, made with indicators of physical, mental and behavioural functioning, demonstrated that ascending complexity in reaction time measurements can be used as an evaluation of the degree of mental deterioration. An example of the use of the apparatus in the evaluation of the improvement after treatment with suloctidil is given.</p>","PeriodicalId":19862,"journal":{"name":"Pharmatherapeutica","volume":"4 8","pages":"510-24"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14145704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmatherapeutica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1